Benitec Biopharma (BNTC) Accumulated Expenses (2019 - 2025)
Benitec Biopharma (BNTC) reported Accumulated Expenses of $483000.0 for Q4 2025, down 10.06% on a YoY basis from $537000.0 in Q4 2024, and up 4.32% sequentially from $463000.0 in Q3 2025.
Benitec Biopharma (BNTC) Accumulated Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Accumulated Expenses data on file, last reported at $483000.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses fell 10.06% year-over-year to $483000.0; the trailing twelve-month figure through Dec 2025 stood at $483000.0 (down 10.06% YoY), and the FY2025 full-year result was $426000.0, down 10.32% from the prior year.
- Accumulated Expenses rose to $483000.0 in Q4 2025, from $463000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.5 million in Q1 2023 to a low of $231000.0 in Q1 2021.
- A 5-year average of $744000.0 and a median of $479000.0 in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses jumped 471.43% in 2022 and plunged 78.94% in 2024, its largest moves.
- Tracing BNTC's Accumulated Expenses over 5 years: stood at $321000.0 in 2021, then soared by 470.09% to $1.8 million in 2022, then slumped by 71.42% to $523000.0 in 2023, then grew by 2.68% to $537000.0 in 2024, then declined by 10.06% to $483000.0 in 2025.
- Business Quant data shows BNTC's Accumulated Expenses at $483000.0 in Q4 2025, $463000.0 in Q3 2025, and $426000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 463,000.00 |
| Jun 30, 2025 | 426,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 537,000.00 |
| Sep 30, 2024 | 495,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 523,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 472,000.00 |
| Mar 31, 2023 | 2.46 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 385,000.00 |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 321,000.00 |
| Sep 30, 2021 | 301,000.00 |
| Jun 30, 2021 | 880,000.00 |
| Mar 31, 2021 | 231,000.00 |